$PAND +133% today an acquisition news

$PAND who is a clinical stage biopharmaceutical company developing novel therapeutics designed to address the unmet needs of patients suffering from autoimmune diseases just today after Merck & Co ($MRK) offer $60 per share in cash.

Here is the link of the press release.

Here is the graph of the day.

 

Here is the 30-day overview.

You May Also Like

$ORPH + 301%

$AEMD +388%

$AMC did very well today +95%

$BCTX +92% today or positive results for breast cancer.

Leave a Reply

Your email address will not be published. Required fields are marked *

EMAIL SIGNUP